MDT
Medtronic plc
NYSEUSDEQUITY
Healthcare
DELAYED
Neutral
0/100
Last price
87.09
▼ 0.88 (1.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
88.25
Prev close
87.97
Day high
88.50
Day low
86.45
Volume
52.13M
Market cap
$111.40B
P/E (TTM)
21.61
52W range
73.31 – 106.33
Day trading desk
Gap from prior close
+0.32%
Prior close 87.97
VWAP
87.00
+0.10% from price
Relative volume
15.02×
Unusually busy
Session range
2.38%
86.44 – 88.50
Position in range
31%
Mid range
ATR (14D)
1.91
2.19% of price
Prior day high
88.12
PDH
Prior day low
85.53
PDL
Bid / ask spread
—
Quote not published
Session volume
160.45M
Avg 10.68M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
0.00%
-1.9%
1M
-7.52%
-8.7%
3M
+6.19%
+1.7%
6M
+0.78%
-17.4%
YTD
-9.34%
-23.6%
1Y
-10.86%
-27.3%
3Y
+11.14%
-71.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on MDT open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+322.62K
Net buying
Buy transactions
27
331.39K shares
Sell transactions
3
8.77K shares
Net transactions
+30
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
4.46M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 16, 26 | KIIL HARRY SKIP Officer |
SELL | 1.48K | $138.88K | Direct |
| Sep 15, 26 | BLOMQUIST DENISE L Officer |
STOCK | 600 | $0 | Direct |
| Aug 3, 26 | THOMPSON KWELI Officer |
STOCK | 6.92K | $0 | Direct |
| Aug 3, 26 | MARTHA GEOFFREY S Chief Executive Officer |
STOCK | 41.53K | $0 | Direct |
| Aug 3, 26 | QUINN MICHELLE General Counsel |
STOCK | 6.35K | $0 | Direct |
| Aug 3, 26 | MARINARO MICHAEL Officer |
STOCK | 57.11K | $0 | Direct |
| Aug 3, 26 | WALTER MATTHEW R. Officer |
STOCK | 5.77K | $0 | Direct |
| Aug 3, 26 | PIETON THIERRY JEAN LOUIS Chief Financial Officer |
STOCK | 11.54K | $0 | Direct |
| Aug 3, 26 | BLOMQUIST DENISE L Officer |
STOCK | 2.34K | $0 | Direct |
| Aug 3, 26 | KIIL HARRY SKIP Officer |
STOCK | 9.23K | $0 | Direct |
| Jul 8, 26 | WALTER MATTHEW R. Officer |
SELL | 3.10K | $257.93K | Direct |
| Jun 8, 26 | KIIL HARRY SKIP Officer |
SELL | 4.19K | $336.96K | Direct |
| May 26, 26 | WALL BRETT A Officer |
— | 26.91K | — | Direct |
| May 26, 26 | MARINARO MICHAEL Officer |
— | 18.99K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ARNOLD CRAIG |
Director | 42.19K | Stock Award(Grant) |
CORONA GARY LOUIS |
Chief Financial Officer | 44.26K | Stock Award(Grant) |
HOGAN RANDALL J III |
Director | 49.00K | Stock Award(Grant) |
KIIL HARRY SKIP |
Officer | 42.19K | Sale |
MARINARO MICHAEL |
Officer | 117.42K | Stock Award(Grant) |
MARTHA GEOFFREY S |
Chief Executive Officer | 327.87K | Stock Award(Grant) |
PIETON THIERRY JEAN LOUIS |
Chief Financial Officer | 49.65K | Stock Award(Grant) |
POWELL KENDALL J |
Director | 51.38K | Stock Award(Grant) |
SMITH GREGORY L |
Officer | 46.02K | Sale |
WALL BRETT A |
Officer | 82.18K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$111.40B
Enterprise value$131.35B
Revenue (TTM)$37.54B
Gross profit$24.50B
EBITDA$10.41B
Net income$5.23B
EPS (TTM)$4.03
Free cash flow$5.41B
Total cash$8.82B
Total debt$28.15B
Book value / share$39.24
Shares outstanding1.28B
Float1.28B
Short % of float1.35%
Dividend yield3.27%
Beta (5Y)0.57
Valuation & profitability ratios
Trailing P/E21.61
Forward P/E13.58
PEG ratio1.58
Price / sales—
Price / book2.22
EV / revenue3.50
EV / EBITDA12.62
Gross margin65.27%
Operating margin19.33%
Profit margin13.93%
Return on equity10.65%
Return on assets5.12%
Debt / equity55.37
Current ratio2.07
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $36.36B | $33.54B | $32.36B | $31.23B | +8.4% |
| Operating revenue | $36.36B | $33.54B | $32.36B | $31.23B | +8.4% |
| Cost of revenue | $12.72B | $11.63B | $11.22B | $10.72B | +9.4% |
| Gross profit | $23.64B | $21.91B | $21.15B | $20.51B | +7.9% |
| Research & development | $2.87B | $2.73B | $2.73B | $2.70B | +5.2% |
| Selling, general & admin | $11.78B | $10.85B | $10.74B | $10.41B | +8.6% |
| Total operating expense | $16.82B | $15.37B | $15.63B | $14.68B | +9.4% |
| Operating income | $6.83B | $6.54B | $5.52B | $5.83B | +4.4% |
| Net interest income | -$715.00M | -$729.00M | -$719.00M | -$636.00M | +1.9% |
| Pre-tax income | $6.14B | $5.63B | $4.84B | $5.36B | +9.0% |
| Tax provision | $1.30B | $936.00M | $1.13B | $1.58B | +38.8% |
| Net income | $4.80B | $4.66B | $3.68B | $3.76B | +3.0% |
| Net income to common | $4.80B | $4.66B | $3.68B | $3.76B | +3.0% |
| Basic EPS | 3.75 | 3.63 | 2.77 | 2.83 | +3.3% |
| Diluted EPS | 3.73 | 3.61 | 2.76 | 2.82 | +3.3% |
| EBIT | $6.85B | $6.36B | $5.56B | $6.00B | +7.8% |
| EBITDA | $9.81B | $9.22B | $8.20B | $8.70B | +6.4% |
| Basic shares | 1.28B | 1.29B | 1.33B | 1.33B | -0.3% |
| Diluted shares | 1.29B | 1.29B | 1.33B | 1.33B | -0.1% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.95B | $2.22B | $1.28B | $1.54B | -12.1% |
| Cash & short-term investments | $9.22B | $8.96B | $8.01B | $7.96B | +2.8% |
| Accounts receivable | $6.64B | $6.51B | $6.13B | $6.00B | +2.0% |
| Inventory | $5.95B | $5.48B | $5.22B | $5.29B | +8.7% |
| Total current assets | $24.79B | $23.81B | $21.93B | $21.68B | +4.1% |
| Property, plant & equipment | $7.42B | $6.84B | $6.13B | $5.57B | +8.5% |
| Goodwill & intangibles | $52.73B | $53.40B | $54.21B | $56.27B | -1.3% |
| Total assets | $93.03B | $91.68B | $89.98B | $90.95B | +1.5% |
| Total current liabilities | $11.66B | $12.88B | $10.79B | $9.05B | -9.5% |
| Current debt | $1.78B | $2.87B | $1.09B | $13.00M | -37.9% |
| Long-term debt | $26.12B | $25.59B | $23.88B | $24.29B | +2.1% |
| Total debt | $27.96B | $28.52B | $25.02B | $24.36B | -1.9% |
| Total liabilities | $42.96B | $43.42B | $39.56B | $39.28B | -1.1% |
| Retained earnings | $32.64B | $31.48B | $30.40B | $30.39B | +3.7% |
| Shareholder equity | $49.46B | $48.02B | $50.21B | $51.48B | +3.0% |
| Working capital | $13.13B | $10.94B | $11.15B | $12.62B | +20.1% |
| Net tangible assets | -$3.27B | -$5.38B | -$4.00B | -$4.79B | +39.2% |
| Shares issued | 1.28B | 1.28B | 1.31B | 1.33B | -0.1% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $4.84B | $4.69B | $3.71B | $3.78B | +3.1% |
| Depreciation & amortisation | $2.96B | $2.86B | $2.65B | $2.70B | +3.4% |
| Stock-based compensation | $457.00M | $429.00M | $393.00M | $355.00M | +6.5% |
| Change in working capital | -$1.42B | -$1.05B | -$484.00M | -$967.00M | -35.0% |
| Operating cash flow | $7.33B | $7.04B | $6.79B | $6.04B | +4.1% |
| Capital expenditure | -$1.90B | -$1.86B | -$1.59B | -$1.46B | -2.4% |
| Investing cash flow | -$2.93B | -$1.94B | -$2.37B | -$3.49B | -51.5% |
| Share buybacks | -$1.03B | -$3.23B | -$2.14B | -$645.00M | +68.0% |
| Dividends paid | -$3.64B | -$3.59B | -$3.67B | -$3.62B | -1.4% |
| Financing cash flow | -$4.75B | -$4.36B | -$4.45B | -$4.96B | -8.9% |
| Free cash flow | $5.43B | $5.18B | $5.20B | $4.58B | +4.6% |
| End cash position | $1.95B | $2.22B | $1.28B | $1.54B | -12.1% |
| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $9.76B | $9.81B | $9.02B | $8.96B | $8.58B | -0.5% |
| Operating revenue | $9.76B | $9.81B | $9.02B | $8.96B | $8.58B | -0.5% |
| Cost of revenue | $3.42B | $3.40B | $3.26B | $3.06B | $3.00B | +0.5% |
| Gross profit | $6.34B | $6.41B | $5.76B | $5.90B | $5.58B | -1.1% |
| Research & development | $771.00M | $671.00M | $722.00M | $754.00M | $726.00M | +14.9% |
| Selling, general & admin | $3.20B | $3.06B | $2.96B | $2.96B | $2.81B | +4.6% |
| Total operating expense | $4.50B | $4.40B | $4.15B | $4.20B | $4.06B | +2.5% |
| Operating income | $1.84B | $2.01B | $1.60B | $1.70B | $1.52B | -8.8% |
| Net interest income | -$186.00M | -$176.00M | -$181.00M | -$181.00M | -$176.00M | -5.7% |
| Pre-tax income | $1.77B | $1.83B | $1.40B | $1.60B | $1.30B | -3.5% |
| Tax provision | $289.00M | $575.00M | $254.00M | $215.00M | $255.00M | -49.7% |
| Net income | $1.47B | $1.24B | $1.14B | $1.37B | $1.04B | +18.2% |
| Net income to common | $1.47B | $1.24B | $1.14B | $1.37B | $1.04B | +18.2% |
| Basic EPS | 1.15 | 0.97 | 0.89 | 1.07 | 0.81 | +18.6% |
| Diluted EPS | 1.14 | 0.96 | 0.89 | 1.07 | 0.81 | +18.7% |
| EBIT | $1.96B | $2.01B | $1.58B | $1.78B | $1.48B | -2.7% |
| EBITDA | $2.68B | $2.73B | $2.33B | $2.52B | $2.23B | -1.5% |
| Basic shares | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | -0.1% |
| Diluted shares | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | -0.2% |
| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.69B | $1.95B | $1.15B | $1.28B | $1.27B | -13.2% |
| Cash & short-term investments | $8.82B | $9.22B | $8.38B | $8.33B | $8.12B | -4.3% |
| Accounts receivable | $6.36B | $6.64B | $6.36B | $6.39B | $6.26B | -4.3% |
| Inventory | $6.21B | $5.95B | $6.31B | $6.16B | $5.89B | +4.4% |
| Total current assets | $24.39B | $24.79B | $24.07B | $24.00B | $23.22B | -1.6% |
| Property, plant & equipment | $7.47B | $7.42B | $7.18B | $7.16B | $7.01B | +0.8% |
| Goodwill & intangibles | $53.42B | $52.73B | $52.23B | $52.58B | $53.23B | +1.3% |
| Total assets | $93.31B | $93.03B | $91.48B | $91.35B | $90.97B | +0.3% |
| Total current liabilities | $11.80B | $11.66B | $9.49B | $9.94B | $11.53B | +1.2% |
| Current debt | $2.54B | $1.78B | $191.00M | $1.42B | $2.43B | +42.3% |
| Long-term debt | $25.57B | $26.12B | $27.82B | $27.63B | $26.13B | -2.1% |
| Total debt | $28.15B | $27.96B | $28.07B | $29.10B | $28.61B | +0.7% |
| Total liabilities | $42.46B | $42.96B | $42.29B | $42.49B | $42.84B | -1.2% |
| Retained earnings | $33.19B | $32.64B | $32.30B | $32.07B | $31.61B | +1.7% |
| Shareholder equity | $50.23B | $49.46B | $48.98B | $48.65B | $47.89B | +1.6% |
| Working capital | $12.59B | $13.13B | $14.58B | $14.06B | $11.69B | -4.1% |
| Net tangible assets | -$3.19B | -$3.27B | -$3.24B | -$3.93B | -$5.34B | +2.4% |
| Shares issued | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | -0.0% |
| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $1.48B | $1.26B | $1.15B | $1.38B | $1.05B | +17.5% |
| Depreciation & amortisation | $729.00M | $716.00M | $749.00M | $745.00M | $748.00M | +1.8% |
| Stock-based compensation | $125.00M | $95.00M | $94.00M | $182.00M | $86.00M | +31.6% |
| Change in working capital | -$665.00M | $444.00M | $702.00M | -$1.42B | -$1.15B | -249.8% |
| Operating cash flow | $1.79B | $2.57B | $2.74B | $925.00M | $1.09B | -30.3% |
| Capital expenditure | -$503.00M | -$488.00M | -$444.00M | -$468.00M | -$504.00M | -3.1% |
| Investing cash flow | -$1.62B | -$917.00M | -$816.00M | -$482.00M | -$719.00M | -76.6% |
| Share buybacks | -$267.00M | -$435.00M | -$105.00M | -$372.00M | -$123.00M | +38.6% |
| Dividends paid | -$921.00M | -$908.00M | -$911.00M | -$910.00M | -$910.00M | -1.4% |
| Financing cash flow | -$343.00M | -$888.00M | -$2.09B | -$395.00M | -$1.38B | +61.4% |
| Free cash flow | $1.29B | $2.08B | $2.30B | $457.00M | $584.00M | -38.1% |
| End cash position | $1.69B | $1.95B | $1.15B | $1.28B | $1.27B | -13.2% |
Options analytics
Put / call volume
0.85
Call-heavy session
Put / call open interest
0.52
Positioning, not flow
Max pain
87.00
-0.1% from spot
ATM implied vol
55.8%
Nearest strike to spot
Skew (10% OTM)
-37.2%
Calls bid over puts
Call volume
543
Contracts, this expiry
Put volume
463
Contracts, this expiry
Heaviest call OI
88.00
2.69K contracts
Heaviest put OI
87.00
2.16K contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | 1.39 | 1.45 | +4.5% |
| Apr 2026 | 1.54 | 1.55 | +0.6% |
| Jan 2026 | 1.34 | 1.36 | +1.9% |
| Oct 2025 | 1.31 | 1.36 | +3.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.33 | 23 | $9.48B | +5.8% |
| Next quarter | 1.42 | 22 | $9.52B | +5.6% |
| Current year | 5.98 | 28 | $38.98B | +7.3% |
| Next year | 6.41 | 28 | $40.40B | +3.7% |
Analyst targets & ownership
Mean target$104.83
High target$121.00
Low target$85.00
Implied upside20.37%
Analyst count24
ConsensusBUY
Strong buy / Buy3 / 16
Hold9
Sell / Strong sell0 / 0
Held by insiders0.35%
Held by institutions88.65%
Institutions holding2.91K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
87.72
-0.72% from price
SMA 20
89.96
-3.19% from price
SMA 50
90.07
-3.31% from price
SMA 100
85.08
+2.37% from price
SMA 200
88.54
-1.64% from price
EMA 12
88.28
-1.35% from price
EMA 26
89.32
-2.50% from price
EMA 50
88.85
-1.98% from price
RSI (14)
40.5
Neutral
MACD (12,26,9)
-1.04
Hist -0.49
ATR (14)
1.91
2.19% of price
Realised vol 30D
20.4%
Annualised
Bollinger upper
94.93
20, 2σ
Bollinger lower
84.99
20, 2σ
50 / 200 cross
Golden
90.07 vs 88.54
Trend bias
Below 200
-1.64%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.16
Less volatile than market
Correlation to SPY
0.09
Largely independent
Realised vol 30D
20.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-30.0%
Peak to trough
Max drawdown 5Y
-45.7%
Peak to trough
ATR 14
1.91
2.19% of price
Beta (reported)
0.57
5Y monthly, from filing
Short interest
Shares short
17.23M
Prior 14.35M
Change vs prior
+20.1%
Shorts adding
% of float
1.35%
Normal
% of shares out
1.35%
Against total outstanding
Days to cover
2.2
Liquid
Float
1.28B
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 30, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Sep 3, 26 | UBS | MAINTAINED | Buy | Buy |
| Sep 2, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Sep 2, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Sep 2, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Sep 2, 26 | B of A Securities | MAINTAINED | Buy | Buy |
| Sep 2, 26 | Stifel | MAINTAINED | Hold | Hold |
| Sep 2, 26 | Baird | MAINTAINED | Neutral | Neutral |
| Sep 1, 26 | BTIG | MAINTAINED | Buy | Buy |
| Sep 1, 26 | Needham | MAINTAINED | Buy | Buy |
| Aug 28, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Aug 27, 26 | Needham | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate$2.88 / yr
Forward yield3.27%
5-year avg yield3.03%
Payout ratio70.02%
Ex-dividend dateSep 25, 2026
Next pay dateOct 16, 2026
Last split2:1
Split dateSep 27, 1999
SEC filings
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-10-05
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-10-02
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-10-01
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-09-30
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-09-29
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-09-28
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-09-25
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-09-24
Headlines
The "Trumpflation" Trade Could Get Worse Before It Gets Better. History Says These 2 Stocks Are the Place to Hide.
Motley Fool · 15m ago
Better Dividend Play for Retirees: MDT or ABT? One Delivers Significantly More Yield
24/7 Wall St. · 11h ago
Medtronic Impact Report Highlights More Than 82 Million Patients Served Worldwide in Fiscal Year 2026
ACCESS Newswire · 11h ago
Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?
Zacks · 12h ago
What Could Lift ISRG Stock?
Trefis · 13h ago
If The MiniMed Split-Off Stalls, What Happens To Your Medtronic Stock?
Trefis · 15h ago
Is Medtronic (MDT) Undervalued Following Its Permanent CPT Code Win?
Simply Wall St. · 1d ago
Medtronic (MDT) Outperforms Broader Market: What You Need to Know
Zacks · 1d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.